Daniel Morales‐Cano

Author

Daniel Morales‐Cano

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias ORCID

Also Known As

D Morales-Cano, D. Morales, D. Morales-Cano, Daniel Morales, Daniel Morales Cano, Daniel Morales-Cano, Daniel Morales‐Cano, Morales-Cano, Daniel

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias Universidad Complutense de Madrid Hospital General Universitario Gregorio Marañón Spanish National Centre for Cardiovascular Research Universidad de Granada

About

Daniel Morales‐Cano is an author at Centro de Investigación Biomédica en Red de Enfermedades Respiratorias specializing in medicine, physiology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	307
2	Public Health	3	3	77
3	Biochemistry	2	2	54
4	Cell Biology	2	2	87
5	Engineering	1	1	42

Daniel Morales‐Cano

Publications

995

Citations

H-Index

Page 1

	Year	Citations
Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome María Callejo, Gema Mondéjar‐Parreño, Bianca Barreira, Scientific Reports	2018	90
The Flavonoid Quercetin Reverses Pulmonary Hypertension in Rats Daniel Morales‐Cano, Carmen Menéndez, Enrique Moreno, PLoS ONE HypertensionPulmonary Arterial HypertensionCardiovascular DiseaseMedicinePhysiology	2014	76
Kv7 channels critically determine coronary artery reactivity: left-right differences and down-regulation by hyperglycaemia Daniel Morales‐Cano, Laura Moreno, Bianca Barreira, Cardiovascular Research	2015	67
Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunction Rachele Pandolfi, Bianca Barreira, Enrique Moreno, Thorax	2016	62
Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition Daniel Morales‐Cano, Eva Calviño, Virginia Rubio, Experimental and Toxicologic Pathology MedicineApoptosisErk InhibitionCell DeathImmune Checkpoint Inhibitor	2013	59
miR‐1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries Gema Mondéjar‐Parreño, María Callejo, Bianca Barreira, The Journal of Physiology	2018	59
Ceramide Mediates Acute Oxygen Sensing in Vascular Tissues Laura Moreno, Javier Moral‐Sanz, Daniel Morales‐Cano, Antioxidants and Redox Signaling	2013	48
Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy Nura A. Mohamed, Robert P. Davies, Paul D. Lickiss, Pulmonary Circulation NanotherapeuticsInflammatory Lung DiseaseEngineeringLung InflammationImmunology	2017	42
Different patterns of pulmonary vascular disease induced by type 1 diabetes and moderate hypoxia in rats Javier Moral‐Sanz, José Gustavo López‐López, Carmen Menéndez, Experimental Physiology AsthmaType 1Pulmonary Arterial HypertensionHeart FailurePulmonary Circulation	2012	40
Th2 CD4 <sup>+</sup> T Cells Are Necessary and Sufficient for <i>Schistosoma‐</i> Pulmonary Hypertension Rahul Kumar, Claudia Mickael, Biruk Kassa, Journal of the American Heart Association	2019	36

Page 1